Finally, future therapeutic strategies that aim to modify the prion-like propagation of pathological TDP-43 or FUS present another promising avenue for development of precision medicine in the context of TDP-43 or FUS proteinopathies. Here, TARDBP is linked to proteostasis deficiencies.